| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 164,840 | 170,931 | 161,068 | 161,771 | | Cost of Revenue | 133,758 | 138,696 | 133,881 | 135,334 | | | Gross Profit | 31,082 | 32,235 | 27,187 | 26,437 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,617 | 13,117 | 12,991 | 12,937 | | Non Recurring | 428 | 972 | 729 | 14,296 | | Others | 10,060 | 9,313 | 9,353 | 7,824 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,977 | 8,833 | 4,114 | (8,620) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 7,314 | 8,833 | 4,114 | (8,620) | | Interest Expense | (497) | 188 | 309 | 555 | | Income Before Tax | 7,811 | 8,645 | 3,805 | (9,175) | | Income Tax Expense | 2,020 | 2,547 | 1,213 | (3,862) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,791 | 6,098 | 2,592 | (5,313) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,791 | 6,098 | 2,592 | (5,313) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,791 | $6,098 | $2,592 | ($5,313) |
|
0.03% Nasdaq 
0.32 (2.26%) 
Income Statement
